496 related articles for article (PubMed ID: 18178266)
1. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis.
Acosta D; Cancela M; Piacenza L; Roche L; Carmona C; Tort JF
Mol Biochem Parasitol; 2008 Mar; 158(1):52-64. PubMed ID: 18178266
[TBL] [Abstract][Full Text] [Related]
2. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of leucine aminopeptidase from Fasciola gigantica.
Changklungmoa N; Chaithirayanon K; Kueakhai P; Meemon K; Riengrojpitak S; Sobhon P
Exp Parasitol; 2012 Jul; 131(3):283-91. PubMed ID: 22543100
[TBL] [Abstract][Full Text] [Related]
4. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
[TBL] [Abstract][Full Text] [Related]
5. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
[TBL] [Abstract][Full Text] [Related]
6. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
[TBL] [Abstract][Full Text] [Related]
7. A recombinant thioredoxin-glutathione reductase from Fasciola hepatica induces a protective response in rabbits.
Maggioli G; Silveira F; Martín-Alonso JM; Salinas G; Carmona C; Parra F
Exp Parasitol; 2011 Dec; 129(4):323-30. PubMed ID: 21985914
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of a chimeric protein made from Fasciola hepatica leucine aminopeptidase and cathepsin L1.
Hernández-Guzmán K; Sahagún-Ruiz A; Vallecillo AJ; Cruz-Mendoza I; Quiroz-Romero H
J Helminthol; 2016 Jan; 90(1):7-13. PubMed ID: 25274570
[TBL] [Abstract][Full Text] [Related]
9. A promising new target to control fasciolosis: Fasciola hepatica leucine aminopeptidase 2.
Checa J; Salazar C; Goyeche A; Rivera M; Silveira F; Maggioli G
Vet Parasitol; 2023 Aug; 320():109959. PubMed ID: 37329826
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings.
Timoteo O; Maco V; Maco V; Neyra V; Yi PJ; Leguía G; Espinoza JR
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):77-86. PubMed ID: 15910994
[TBL] [Abstract][Full Text] [Related]
11. Fasciola hepatica and Fasciola gigantica: cloning and characterisation of 70 kDa heat-shock proteins reveals variation in HSP70 gene expression between parasite species recovered from sheep.
Smith RE; Spithill TW; Pike RN; Meeusen EN; Piedrafita D
Exp Parasitol; 2008 Apr; 118(4):536-42. PubMed ID: 18190913
[TBL] [Abstract][Full Text] [Related]
12. Characterization and partial purification of a leucine aminopeptidase from Fasciola hepatica.
Acosta D; Goñi F; Carmona C
J Parasitol; 1998 Feb; 84(1):1-7. PubMed ID: 9488329
[TBL] [Abstract][Full Text] [Related]
13. Low allelic diversity in vaccine candidates genes from different locations sustain hope for Fasciola hepatica immunization.
Dominguez MF; González-Miguel J; Carmona C; Dalton JP; Cwiklinski K; Tort J; Siles-Lucas M
Vet Parasitol; 2018 Jul; 258():46-52. PubMed ID: 30105977
[TBL] [Abstract][Full Text] [Related]
14. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
[TBL] [Abstract][Full Text] [Related]
15. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
[TBL] [Abstract][Full Text] [Related]
16. [Influence of vaccination of calves with recombinant cysteine proteinase of Fasciola hepatica on development and infectivity of miracidia].
Dabrowska M; Kaliniak M; Wedrychowicz H
Wiad Parazytol; 2006; 52(4):305-9. PubMed ID: 17432623
[TBL] [Abstract][Full Text] [Related]
17. Humoral response (IgG) of goats experimentally infected with Fasciola hepatica against cysteine proteinases of adult fluke.
Ruiz A; Molina JM; González J; Martínez-Moreno FJ; Gutiérrez PN; Martínez-Moreno A
Vet Res; 2003; 34(4):435-43. PubMed ID: 12911860
[TBL] [Abstract][Full Text] [Related]
18. Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1).
Kesik M; Jedlina-Panasiuk L; Kozak-Cieszczyk M; Płucienniczak A; Wedrychowicz H
Vaccine; 2007 May; 25(18):3619-28. PubMed ID: 17289224
[TBL] [Abstract][Full Text] [Related]
19. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1).
Golden O; Flynn RJ; Read C; Sekiya M; Donnelly SM; Stack C; Dalton JP; Mulcahy G
Vaccine; 2010 Aug; 28(34):5551-7. PubMed ID: 20600503
[TBL] [Abstract][Full Text] [Related]
20. Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.
Marcilla A; De la Rubia JE; Sotillo J; Bernal D; Carmona C; Villavicencio Z; Acosta D; Tort J; Bornay FJ; Esteban JG; Toledo R
Clin Vaccine Immunol; 2008 Jan; 15(1):95-100. PubMed ID: 18003812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
